Are surrogates of IGHV gene mutational status useful in B-cell chronic lymphocytic leukemia? The example of Septin-10 [15]

Leukemia

Volumn 22, Issue 1, 2008, Pages 224-226

  Benedetti, D ^a   Bomben, R ^a   Dal Bo, M ^a   Marconi, D ^b   Zucchetto, A ^a   Degan, M ^a   Forconi, F ^c   Del Poeta, G ^d   Gaidano, G ^e   Gattei, V ^a  

^a CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c UNIVERSITY OF SIENA   (Italy)

^d UNIVERSITY OF ROME TOR VERGATA   (Italy)

^e UNIVERSITY OF EASTERN PIEDMONT   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE RECEPTOR; CYTIDINE DEAMINASE; IMMUNOGLOBULIN HEAVY CHAIN; MESSENGER RNA; PROTEIN KINASE ZAP 70; SEPTIN; SEPTIN 10; UNCLASSIFIED DRUG;

CHRONIC LYMPHATIC LEUKEMIA; DOWN REGULATION; GENE EXPRESSION PROFILING; GENE FUNCTION; GENE MUTATION; LETTER; PRIORITY JOURNAL; PROGNOSIS; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION;

EID: 38349068479     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/sj.leu.2404867     Document Type: Letter

References (8)

1. Bilban M, Heintel D, Scharl T, Woelfel T, Auer MM, Porpaczy E et al Deregulated expression of fat and muscle genes in B-cell chronic lymphocytic leukemia with high lipoprotein lipase expression. Leukemia 2006; 20: 1080-1088.
2. Heintel D, Kienle D, Shehata M, Krober A, Kroemer E, Schwarzinger I et al. High expression of lipoprotein lipase in poor risk B-cell chronic lymphocytic leukemia. Leukemia 2005; 19: 1216-1223.
3. Bomben R, Dal BM, Capello D, Benedetti D, Marconi D, Zucchetto A et al. Comprehensive characterization of IGHV3-21-expressing B-cell chronic lymphocytic leukemia: An Italian multicenter study. Blood 2007; 109: 2989-2998.
4. Tobin G, Thunberg U, Johnson A, Thorn I, Soderberg O, Hultdin M et al Somatically mutated Ig V(H)3-21 genes characterize a new subset of chronic lymphocytic leukemia. Blood 2002; 99: 2262-2264.
5. Ghia P, Stamatopoulos K, Belessi C, Moreno C, Stella S, Guida G et al Geographic patterns and pathogenetic implications of IGHV gene usage in chronic lymphocytic leukemia: The lesson of the IGHV3-21 gene. Blood 2005; 105: 1678-1685.
6. van't Veer MB, Brooijmans AM, Langerak AW, Verhaaf B, Goudswaard CS, Graveland WJ et al. The predictive value of lipoprotein lipase for survival in chronic lymphocytic leukemia. Haematologica 2006; 91: 56-63.
7. Stamatopoulos K, Belessi C, Moreno C, Boudjograh M, Guida G, Smilevska T et al. Over 20% of patients with chronic lymphocytic leukemia carry stereotyped receptors: Pathogenetic implications and clinical correlations. Blood 2007; 109: 259-270.
8. Del Principe MI, Del PG, Buccisano F, Maurillo L, Venditti A, Zucchetto A et al. Clinical significance of ZAP-70 protein expression in B-cell chronic lymphocytic leukemia. Blood 2006; 108: 853-861.